🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

25 recruiting trials

for Urinary Urge Incontinence

Study of 30-Minute Stimulation With the Neuspera Sacral Neuromodulation (SNM) System NCT07247136NA1 site📍 West Columbia Neuspera Medical, Inc. · Tests: Neuspera Implantable Sacral Neuromodulation System Safety and Performance of UCon Patch Electrode NCT06754189NA3 sites📍 Aarhus📍 Herlev📍 Odense InnoCon Medical · Tests: Time Limited stimulation, Sham stimulation Fluoroscopy Radiation Reduction During Sacral Neuromodulation Lead Placement NCT04527445NA1 site📍 Loma Linda Loma Linda University · Tests: Reduced radiation fluoroscopy, Conventional fluoroscopy Randomized Controlled Trial Comparing Low Dose Tadalafil Versus Solifenacin For Management of Overactive Bladder in Women: Multicenter Egyptian National Study NCT07416968Phase 414 sites📍 Shibīn al Kawm📍 Zagazig📍 Al Mansurah Mansoura University · Tests: Tadalafil 5 mg, Solifenacin 5mg Assessing the Genitourinary Microbiome of Women With Overactive Bladder Undergoing Onabotulinum Toxin Type A Intradetrusor Injections NCT07025044n/a1 site📍 Washington D.C. Alexis Dieter · Tests: onabotulinum toxin type a TReating Incontinence for Underlying Mental and Physical Health NCT05362292Phase 42 sites📍 Palo Alto📍 San Francisco University of California, San Francisco · Tests: Tolterodine Tartrate ER, Mirabegron, Placebo Neuspera Revision Registry - Follow up Revision Experience and Evaluation of Device Outcomes Metrics NCT07383688n/a1 site📍 St Louis Neuspera Medical, Inc. · Tests: Neuspera Implantable Sacral Neuromodulation System Post-procedural Pain Associated With 5 Versus 20 Intravesical Injections of Onabotulinumtoxin A NCT04305743Phase 42 sites📍 Washington D.C.📍 Tampa University of South Florida · Tests: OnabotulinumtoxinA 100 UNT Effect of Neuromodulation and Therapeutic Exercise in Urinary Incontinence NCT06783374NA1 site📍 Valencia Fundación Universidad Católica de Valencia San Vicente Márt… · Tests: Neuromodulation, Exercise, Exercise control group, Sham Neuromodulation Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer NCT06161506Phase 21 site📍 Bethesda National Cancer Institute (NCI) · Tests: Elidah Device Aquarius Pilot Study to Evaluate the New Axonics Trial System NCT07335484NA5 sites📍 Birmingham📍 Macon📍 West Columbia Axonics, Inc. · Tests: Axonics External Trial System (ETS) Cefar URO - Symptomatic Treatment of Overactive Bladder NCT06659536NA1 site📍 Paris DJO UK Ltd · Tests: Transcutaneous Tibial Nerve Stimulation (TTNS) with the Cefar Uro Device A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE) NCT05685433NA22 sites📍 Homewood📍 Mobile📍 Little Rock Valencia Technologies Corporation · Tests: eCoin Tibial Nerve Stimulation PMCF Study of the Axonics SNM System Model 5101 (R20) for the Indication of OAB NCT06789406NA6 sites📍 Chicago📍 Columbia📍 Bradford Axonics, Inc. · Tests: Axonics SNM System INS Model 5101 (R20) Vitamin D Treat-to-Target Strategy for Children With Overactive Bladder-Wet NCT06201013NA1 site📍 Chongqing Children's Hospital of Chongqing Medical University · Tests: urotherapy, Solifenacin Succinate, Vitamin D3 Low-intensity Shockwave Therapy Versus Solifenacin for the Treatment of Overactive Bladder in Women NCT07473310Phase 41 site📍 Al Mansurah Mansoura University · Tests: Low intensity shockwave therapy, Oral Solifenacin succinate 5 mg Post Approval Effectiveness and Durability Evaluation of the Altaviva™ Tibial Device NCT07456865NA19 sites📍 Homewood📍 Glendale📍 Idaho Falls MedtronicNeuro · Tests: Altaviva™ system Percutaneous Nerve Evaluation Trial Time NCT06226220NA1 site📍 Chicago University of Chicago · Tests: Sacral neuromodulation Clinical Efficacy Evaluation of Electroacupuncture as Adjuvant Therapy for Female Patients With Overactive Bladder NCT05997992NA1 site📍 New Taipei City Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation · Tests: electroacupuncture, sham acupuncture Implementation of the App Tät®II for Treatment of Urgency and Mixed Urinary Incontinence NCT07038811n/a1 site📍 Östersund Umeå University · Tests: Tät®II Detrusor Nerve Radiofrequency Ablation for Overactive Bladder in Women NCT07209397NA9 sites📍 Palo Alto📍 Washington D.C.📍 Boise InMode MD Ltd. · Tests: Detrusor nerve radiofrequency ablation, Simulated (sham) detrusor nerve radiofrequency ablation UCon Treatment of Overactive Bladder (OAB) in Males NCT05874375NA1 site📍 Maastricht InnoCon Medical · Tests: Urge stimulation, Time limited stimulation Platelet-Rich Plasma Versus Botulinum Toxin for Refractory Overactive Bladder: A Randomized Trial NCT07184307NA1 site📍 Banhā Benha University · Tests: Platelet-Rich Plasma, Intravesical Botulinum Toxin Injection Augmenting Urinary Reflex Activity Study 4 (Including eXtended Indications) NCT06885931NA7 sites📍 Leuven📍 Edegem📍 Ghent Amber Therapeutics Ltd · Tests: Pudendal neuromodulation Safety and Performance of UCon Bar Electrode for the Treatment of Overactive Bladder (OAB) and Bowel Dysfunction (BD) NCT06091566NA3 sites📍 Aarhus📍 Herlev📍 Odense InnoCon Medical · Tests: UCon-Bar
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy